Ticker reaction data · Healthcare

Aeglea BioTherapeutics, Inc. (AGLE)

How AGLE actually reacts to news — the realized, point-in-time move the market made, measured across 47 labeled events over the last three years with zero look-ahead.

The quantified answer

AGLE’s median reaction, across the day.

0.00%
Median 30-min
Typical reaction 30 minutes after any AGLE news
41%
Moved up
Share of AGLE news events that rose at 30 minutes
+2.82%
Median to close
Where AGLE typically settles by the closing bell
AGLE median reaction to newsAGLE median reaction to news across 2 horizons: 30-min +0.00%, to close +2.82%.30-minto close30-min: +0.00%to close: +2.82%+0.00%+2.82%0+2.82%
Median move vs. the price at the news timestamp, across 47 labeled events.

Half of all Aeglea BioTherapeutics, Inc. news events land between -0.02% and +0.56% at 30 minutes.

Reaction stats as of 2026-08-18. Reaction = percent move vs. the price at the news timestamp.

Next time, know first

Email me when AGLE moves on news.

One email per qualifying move — the headline, the measured reaction, and how it compares to AGLE’s baseline. Nothing else.

AGLE Free · unsubscribe anytime
26M+ news records Operating since 2012 Methodology on SSRN ↗
Prefer a one-pager?

Get “How AGLE reacts to news” as a PDF.

A free one-page summary: AGLE’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.

Free · your email joins the AGLE alert list · unsubscribe anytime
Latest news

Recent AGLE events, each with its measured reaction.

DateHeadlineEventSource5-minTo close
Form 8-K Spyre Therapeutics, Inc. For: Dec 07SEC filing · Form 8-KSEC EDGAR
Form 8-K Spyre Therapeutics, Inc. For: Nov 22SEC filing · Form 8-KSEC EDGAR
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBDPress releasePR Newswire+0.00%+10.49%
Form 8-K Aeglea BioTherapeutics, For: Nov 21SEC filing · Form 8-KSEC EDGAR+4.54%
Aeglea BioTherapeutics Announces Grants of Inducement AwardsPress releasePR Newswire+4.54%
Form EFFECT Aeglea BioTherapeutics,SEC filing · Form EFFECTSEC EDGAR+0.19%-7.26%
Form 8-K Aeglea BioTherapeutics, For: Nov 15SEC filing · Form 8-KSEC EDGAR+0.00%-7.24%
Form S-1/A Aeglea BioTherapeutics,SEC filing · Form S-1SEC EDGAR+0.00%-7.24%
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatePress releasePR Newswire+0.00%+2.82%
Form 10-Q Aeglea BioTherapeutics, For: Sep 30SEC filing · Form 10-QSEC EDGAR+0.00%+2.82%
Form 8-K Aeglea BioTherapeutics, For: Nov 09SEC filing · Form 8-KSEC EDGAR+0.00%+2.82%
Aeglea BioTherapeutics Announces Grants of Inducement AwardsPress releasePR Newswire-7.52%
Aeglea BioTherapeutics to Participate in Upcoming November Investor ConferencesPress releasePR Newswire+0.00%+1.13%
Form DEF 14A Aeglea BioTherapeutics, For: Nov 21SEC filing · Form DEFSEC EDGAR+0.00%-5.50%
Form 8-K Aeglea BioTherapeutics, For: Oct 24SEC filing · Form 8-KSEC EDGAR-6.53%
Form 8-K Aeglea BioTherapeutics, For: Jun 22SEC filing · Form 8-KSEC EDGAR+0.00%+8.08%
Form PRER14A Aeglea BioTherapeutics,SEC filing · Form PRER14ASEC EDGAR+0.00%+8.08%
Form S-1/A Aeglea BioTherapeutics,SEC filing · Form S-1SEC EDGAR+0.00%+8.08%
Form 8-K Aeglea BioTherapeutics, For: Sep 29SEC filing · Form 8-KSEC EDGAR-9.97%+8.49%
Aeglea BioTherapeutics Announces Grants of Inducement AwardsPress releasePR Newswire-0.34%-4.72%
Form 8-K Aeglea BioTherapeutics, For: Sep 19SEC filing · Form 8-KSEC EDGAR-2.58%
Aeglea BioTherapeutics to Participate in Upcoming September ConferencePress releasePR Newswire+0.00%-0.79%
Form 8-K Aeglea BioTherapeutics, For: Sep 07SEC filing · Form 8-KSEC EDGAR+0.00%+4.62%
Aeglea BioTherapeutics Announces Reverse Stock SplitPress releasePR Newswire-2.26%+21.04%
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-JonesPress releasePR Newswire+1.83%+2.85%
Form 8-K Aeglea BioTherapeutics, For: Aug 31SEC filing · Form 8-KSEC EDGAR+1.83%+2.85%

Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AGLE section they belong to.

Keep exploring

More of the dataset.

AGLE earnings → · Analyst actions → · SEC filings →

Every ticker we measure the same way24

Apple (AAPL)

How AAPL actually reacts to news, measured.

NVIDIA (NVDA)

How NVDA actually reacts to news, measured.

Tesla (TSLA)

How TSLA actually reacts to news, measured.

Microsoft (MSFT)

How MSFT actually reacts to news, measured.

Advanced Micro Devices (AMD)

How AMD actually reacts to news, measured.

Amazon (AMZN)

How AMZN actually reacts to news, measured.

Alphabet (GOOG)

How GOOG actually reacts to news, measured.

Meta Platforms (META)

How META actually reacts to news, measured.

Broadcom (AVGO)

How AVGO actually reacts to news, measured.

JPMorgan Chase (JPM)

How JPM actually reacts to news, measured.

Visa (V)

How V actually reacts to news, measured.

Walmart (WMT)

How WMT actually reacts to news, measured.

Eli Lilly (LLY)

How LLY actually reacts to news, measured.

UnitedHealth Group (UNH)

How UNH actually reacts to news, measured.

Netflix (NFLX)

How NFLX actually reacts to news, measured.

Johnson & Johnson (JNJ)

How JNJ actually reacts to news, measured.

Exxon Mobil (XOM)

How XOM actually reacts to news, measured.

Home Depot (HD)

How HD actually reacts to news, measured.

Costco (COST)

How COST actually reacts to news, measured.

Mastercard (MA)

How MA actually reacts to news, measured.

Oracle (ORCL)

How ORCL actually reacts to news, measured.

Salesforce (CRM)

How CRM actually reacts to news, measured.

Bank of America (BAC)

How BAC actually reacts to news, measured.

Coca-Cola (KO)

How KO actually reacts to news, measured.

Walt Disney (DIS)

How DIS actually reacts to news, measured.

Browse all tickers

Every name we’ve measured, in one place.

Method

How the numbers are made.

How is Aeglea BioTherapeutics, Inc.'s median reaction calculated?

Every labeled AGLE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 47 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.

What counts as a positive reaction?

Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of AGLE's measured events are up at 30 minutes; the rest close the window flat or negative.

How often is this page updated?

The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-18.

Does AGLE's past reaction predict its next one?

No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.

Stop guessing what the event means

You just saw one reaction.
There are 26 million more.

For investors

Know the next move, measured.

Ticker alerts with the realized reaction — not the headline spin. Or create a free account: the full dashboard, every ticker.

Free · no credit card · unsubscribe anytime
For builders

The dataset, one command away.

claude mcp add news-quantified

Then ask Claude: “how does AGLE react to downgrades?” — or pull it raw via REST.

60-second signup on the NQ portal · 1,000 free credits/mo
26M+ news records, 2006–2026 Operating since 2012 Point-in-time, zero look-ahead Peer-reviewable methodology (SSRN) ↗